Pilot Study of rhBMP-2/BCP in Patients With Spinal Degeneration With Instability Requiring Surgic… (NCT01495234) | Clinical Trial Compass
CompletedNot Applicable
Pilot Study of rhBMP-2/BCP in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion
15 participantsStarted 1996-10
Plain-language summary
This study is designed to generate data relating to patient safety, bone generating activity associated with the use of the rhBMP-2/BCP device as compared to autograft and to evaluate the feasibility of conducting a larger clinical trial in a patient population requiring spinal fusion.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject has radiographically documented spinal degeneration with instability as documented by the presence of translation \>= 4mm or angulation \>= 5°.
* Subject has intractable back pain which does not respond to conservative treatment and in the investigator's opinion, requires surgical spinal fusion.
* Subject's pain is predominantly associated with the back.
* Subject has only one level involvement at L3-L4, L4-L5, or L5-S1.
* Subject is 18 years of age or greater at the time consent is given to participate in the study.
* Subject is willing to comply with the study plan and sign the informed consent.
* Subject is male or a non-pregnant, non-nursing female. All females of child-bearing age must agree to use adequate contraception for a period of no less than 16 weeks following surgery.
Exclusion Criteria:
* Subject has primary spinal diagnosis of a disorder other than spinal degeneration with instability at the involved surgical level.
* Subject has spinal stenosis or condition which requires a full laminectomy procedure.
* Subject has had a previous fusion, discectomy or laminectomy procedure at L3-L4, L4-L5 or L5-S1.
* Subject has received drugs which may interfere with bone metabolism within two weeks prior to the planned date of spinal fusion surgery (e.g., steroids, methotrexate) or has a condition which requires postoperative medications that interfere with fusion (e.g., steroids, nonsteroidal antiinflammatory drugs, or methotrexate).
* Subj…